Home ENGLISH

ENGLISH

Latest

Agios blood cancer drug lead jumps ship to Aprea Therapeutics

admin -
0

IBM tech explains why some cancer cells die in response to treatment and others...

admin -
0

Biotech IPOs keep coming as Gilead-backed Hookipa Pharma guns for $86M

admin -
0

U.K. biotech funding climbs 35% in fast start to 2019

admin -
0

Inflazome grabs Fox Foundation funding for Parkinson’s R&D

admin -
0

Conatus and Novartis suffer another midphase NASH flop

admin -
0

J&J dumps Alios RSV drug, wiping remaining $900M off value

admin -
0

Chutes & Ladders—Two senior Genentech executives make the leap to smaller biotechs

admin -
0

Forma Therapeutics nabs long-time Genentech commercial executive as CEO

admin -
0

Ely Benaim to leave Rexahn, take CMO role at Novocure

admin -
0

Alexion strikes Zealand deal to further pipeline rebuild

admin -
0

Biogen hit by ‘transformative failure’ as it cans aducanumab tests

admin -
0

Celgene taps Exscientia’s AI drug discovery tech for 3 new programs

admin -
0

As Merck boosts R&D pact, NGM Bio gains Genentech, Lilly veteran as new R&D...

admin -
0

Alexion strikes another anti-FcRn deal, bagging Affibody drug

admin -
0

Pfizer eyes Fierce 15 winner Vivet buy as gene therapy fever heats up

admin -
0

Merck doubles down on NGM Bio pact but culls obesity drug

admin -
0

WHO panel pushes for genome editing research registry

admin -
0
123...1,486Page 1 of 1,486
©